{
    "id": 50804,
    "name": "glioblastoma proneural subtype",
    "source": "DOID",
    "definition": "A glioblastoma multiforme that is characterized by IDH1 and p53 mutations and Platelet Derived Growth Factor A amplification. [url:http\\://cancergenome.nih.gov/researchhighlights/researchbriefs/foursubtypes, url:https\\://www.ncbi.nlm.nih.gov/pubmed/20129251, url:https\\://www.ncbi.nlm.nih.gov/pubmed/23029035]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:0050804",
    "evidence": [
        {
            "id": 7044,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with Adavosertib (MK-1775) induced apoptosis of mouse proneural glioblastoma cells lacking TP53 and PTEN and over expressing PDGFB in cell culture (PMID: 27196784).",
            "molecularProfile": {
                "id": 24369,
                "profileName": "PDGFB over exp PTEN del TP53 del"
            },
            "therapy": {
                "id": 822,
                "therapyName": "Adavosertib",
                "synonyms": null
            },
            "indication": {
                "id": 50804,
                "name": "glioblastoma proneural subtype",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6050,
                    "pubMedId": 27196784,
                    "title": "Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27196784"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "clinicalTrials": [
        
    ]
}